Nuvalent Inc (NUVL)
86.88
-3.30
(-3.66%)
USD |
NASDAQ |
Nov 15, 16:00
86.84
-0.04
(-0.05%)
After-Hours: 20:00
Nuvalent Cash from Investing (Quarterly): -212.91M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -212.91M |
| June 30, 2024 | 16.21M |
| March 31, 2024 | -206.77M |
| December 31, 2023 | -56.26M |
| September 30, 2023 | 38.40M |
| June 30, 2023 | 1.594M |
| March 31, 2023 | -127.26M |
| December 31, 2022 | -65.40M |
| September 30, 2022 | 17.57M |
| Date | Value |
|---|---|
| June 30, 2022 | 24.11M |
| March 31, 2022 | 13.06M |
| December 31, 2021 | -163.46M |
| September 30, 2021 | -56.57M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-212.91M
Minimum
Sep 2024
38.40M
Maximum
Sep 2023
-45.75M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Viking Therapeutics Inc | 25.90M |
| Bristol-Myers Squibb Co | -219.00M |
| Replimune Group Inc | 0.458M |
| Moderna Inc | 721.00M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -45.82M |
| Cash from Financing (Quarterly) | 550.27M |
| Free Cash Flow | -153.27M |
| Free Cash Flow Per Share (Quarterly) | -0.6976 |
| Free Cash Flow Yield | -2.75% |